L3VLUP
← Every manager
Free · no sign-up · Q2 2026

Which funds own VKTX

Viking Therapeutics Inc in the Q2 2026 filings. None of the 91 current managers lists the shares among its largest positions. What is here is options, which is a position on where the price goes rather than a stake in the thing itself.

Managers holding
0
at least, of 91 current
Combined value
$0
as reported
Opened
0
new this quarter
Added to
0
already held
Trimmed or sold out
0
0 sold out entirely

Only each manager’s largest 200 positions are listed here, so a smaller holder may be missing.

Ownership through time

At least 4 of the 95 managers whose filings are on file listed VKTX in Q2 2026, against 1 in Q2 2018. 2 managers more than in Q1 2026: 1 started a position; 2 listed it again; 1 no longer listed it among the positions read, which can mean a holding below the listed range, a filing that reported no holdings, or a filing not yet made.

Each manager’s largest 500 positions a quarter are read, so a small holding in a very large book can be missing, and a manager is counted as leaving only where its own filing shows it.

Managers on file listing it
047Q2 2018: 1Q3 2018: 3Q4 2018: 1Q1 2019: 119Q2 2019: 2Q3 2019: 1Q4 2020: 1Q1 2021: 121Q2 2021: 2Q3 2021: 2Q4 2021: 1Q1 2022: 122Q2 2022: 1Q3 2022: 2Q4 2022: 3Q1 2023: 423Q2 2023: 1Q3 2023: 3Q4 2023: 2Q1 2024: 724Q2 2024: 5Q3 2024: 5Q4 2024: 6Q1 2025: 425Q2 2025: 3Q3 2025: 6Q4 2025: 6Q1 2026: 226Q2 2026: 4
  • Q2 2018: 1
  • Q3 2018: 3
  • Q4 2018: 1
  • Q1 2019: 1
  • Q2 2019: 2
  • Q3 2019: 1
  • Q4 2020: 1
  • Q1 2021: 1
  • Q2 2021: 2
  • Q3 2021: 2
  • Q4 2021: 1
  • Q1 2022: 1
  • Q2 2022: 1
  • Q3 2022: 2
  • Q4 2022: 3
  • Q1 2023: 4
  • Q2 2023: 1
  • Q3 2023: 3
  • Q4 2023: 2
  • Q1 2024: 7
  • Q2 2024: 5
  • Q3 2024: 5
  • Q4 2024: 6
  • Q1 2025: 4
  • Q2 2025: 3
  • Q3 2025: 6
  • Q4 2025: 6
  • Q1 2026: 2
  • Q2 2026: 4
Their combined reported value
$0$799m$2bnQ2 2018: $949kQ3 2018: $20mQ4 2018: $161kQ1 2019: $6.5m19Q2 2019: $5.4mQ3 2019: $751kQ4 2020: $112kQ1 2021: $245k21Q2 2021: $1.0mQ3 2021: $769kQ4 2021: $627kQ1 2022: $290k22Q2 2022: $849kQ3 2022: $3.5mQ4 2022: $13mQ1 2023: $71m23Q2 2023: $57mQ3 2023: $54mQ4 2023: $138mQ1 2024: $1.6bn24Q2 2024: $961mQ3 2024: $1.1bnQ4 2024: $794mQ1 2025: $61m25Q2 2025: $72mQ3 2025: $117mQ4 2025: $202mQ1 2026: $156m26Q2 2026: $183m
  • Q2 2018: $949k
  • Q3 2018: $20m
  • Q4 2018: $161k
  • Q1 2019: $6.5m
  • Q2 2019: $5.4m
  • Q3 2019: $751k
  • Q4 2020: $112k
  • Q1 2021: $245k
  • Q2 2021: $1.0m
  • Q3 2021: $769k
  • Q4 2021: $627k
  • Q1 2022: $290k
  • Q2 2022: $849k
  • Q3 2022: $3.5m
  • Q4 2022: $13m
  • Q1 2023: $71m
  • Q2 2023: $57m
  • Q3 2023: $54m
  • Q4 2023: $138m
  • Q1 2024: $1.6bn
  • Q2 2024: $961m
  • Q3 2024: $1.1bn
  • Q4 2024: $794m
  • Q1 2025: $61m
  • Q2 2025: $72m
  • Q3 2025: $117m
  • Q4 2025: $202m
  • Q1 2026: $156m
  • Q2 2026: $183m

Between the quarter ends of Q1 2026 and Q2 2026. Each change in shares is valued at the Q2 2026 price, so the price’s own move is left out; a 13F shows the two quarter ends, not when in between anything was bought or sold.

Started in Q2 2026

Largest increases, by shares

Largest decreases, by shares

Left it

No manager on file is shown leaving it.

ManagerValue over timeFirst listedLargestQ2 2026
Two Sigma Investments LPQ4 2022$154m$154m
ExodusPoint Capital Management LPQ3 2024$25m$14m
Woodline Partners LPQ1 2024$12m$12m
Winton Group LtdQ3 2025$3.5m$3.5m
Fidelity (FMR LLC)Q1 2024$1.3bnlast listed Q4 2024
AllianceBernstein LPQ1 2024$128mlast listed Q1 2024
Viking Global Investors LPQ1 2023$96mlast listed Q3 2024
Two Sigma Advisers LPQ1 2023$75mlast listed Q4 2025
MFS Investment ManagementQ4 2024$55mlast listed Q4 2024
Balyasny Asset Management LLCQ3 2018$42mlast listed Q1 2025
Marshall Wace LLPQ1 2024$30mlast listed Q1 2024
Point72 Asset Management LPQ1 2023$18mlast listed Q1 2023
Man Group PLCQ4 2024$18mlast listed Q4 2024
Voloridge Investment Management LLCQ3 2018$12mlast listed Q1 2026

Reported as options rather than shares

A put or a call on a name is not a position in it, and the filing states the notional rather than what the option cost. These lines are listed apart for that reason and are not counted in anything above.

What VKTX is worth

Knowing who owns it is half the question. The other half is what it is worth against the companies it trades beside, which is the one an interviewer will follow up with.

Build the comp set around VKTX →

How much of the picture this is

A Form 13F reports US-listed long equity and nothing else: no shorts, no bonds, no cash and no non-US listings. It arrives forty-five days after the quarter ends, so a manager who sold in July still shows the position in a filing published in August. This page reads the managers on file here rather than every filer in the market, and each manager’s largest positions rather than the whole table, so a small position in a very large book may not appear. Say “their last filing showed” rather than “they own”, and the distinction will do you credit.

What to do with a name the funds are buying

Knowing who owns something is the start of a pitch, not the pitch. The next questions are what it is worth and why they were buying.

Company names, tickers and logos are the trademarks of their respective owners and appear here to identify the company whose public figures are being used. L3VLUP is not affiliated with, sponsored by or endorsed by any company shown, and nothing here is a statement by or about that company. More

The holdings, every quarter, and the week between

One email a week on what moved in the market and what it means for the people interviewing into it, with the 13F changes the quarter they are filed.

One email a week, free, and you can leave at any point.